Home
>
Isotope Labeled Compounds>Isotope Labeled Inhibitors>
>
Methyl Raloxifene-d4 6-(2,3,4-Tri-O-acetyl-β-D-glycopyranuronate)
For research use only. Not for therapeutic Use.
Methyl Raloxifene-d4 6-(2,3,4-Tri-O-acetyl-β-D-glycopyranuronate) is a deuterated form of methyl raloxifene, a selective estrogen receptor modulator (SERM) used in osteoporosis treatment. The “d4” indicates the presence of four deuterium atoms, enhancing its use as a stable isotope-labeled internal standard. The 6-(2,3,4-Tri-O-acetyl-β-D-glycopyranuronate) group refers to a glycopyranuronate moiety with acetyl groups, modifying the compound’s chemical properties. This complex derivative is employed in pharmacokinetic and metabolic studies to precisely measure raloxifene levels and assess its distribution, metabolism, and therapeutic efficacy using advanced analytical techniques.
Catalog Number | R048181 |
CAS Number | NA |
Synonyms | 2-(4-Hydroxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy-d4-benzoyl]benzo[b]thien-6-yl]-2,3,4-tri-O-acetyl-β-D-glucopyranosiduronic Acid Methyl Ester; |
Molecular Formula | C₄₁H₃₉D₄NO₁₃S |
Purity | ≥95% |
Storage | Store at -20°C |